We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Height Loss Associated With Increased Risk of Death

By HospiMedica staff writers
Posted on 19 Jan 2007
Men who lose 3 cm or more of height as they age have an increased risk of death and of coronary heart diseases events, according to a new report.

Researchers from the Royal Free and University College Medical School (RF&UCMS, London, UK) studied 4,213 men who originally enrolled in the British Regional Heart Study between 1978 and 1980. More...
Follow-up examinations were conducted 20 years later, when the men were 60-79 years old. At that time, the men completed a questionnaire providing details about their lifestyle and medical history. Participants' height and weight were measured both at the beginning of the study and at the 20-year follow-up; they were monitored through 2004 to see if they had developed cardiovascular disease, and deaths were tracked through 2005.

Between the initial examination and the 20-year follow-up, the men lost an average of 1.67 cm of height. During an average of five years that they were followed after that, 760 men died. Risk of death increased with height loss and was substantially higher in men who lost 3 cm or more, who were 64% more likely to die during the course of the study than those who lost less than one centimeter. Most of the additional deaths in men who had lost height were attributable to cardiovascular disease, respiratory disease, or other non-cancer diseases. The study was published in December 2006 issue of the Archives of Internal Medicine.

"The significantly increased risk of all-cause mortality in men with a height loss of 3 cm or more was observed even after exclusion of men with a height loss of 4 cm or more,” said lead author S. Goya Wannamethee, Ph.D., and colleagues. "Thus, the increased mortality risk was already seen in men with a height loss in the range of 3-4 centimeters and was not solely attributable to extreme height loss.”



Related Links:
University College Medical School

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.